← Open Payments lookup

ANTHONY CAPOBIANCO: Open Payments

NPI 1659352482 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,150 in 108 payments from 14 companies in 2025. Trend: 2023 $1,244 · 2024 $1,694 · 2025 $2,150

Food & beverage: $2,150
CompanyPaymentsAmount
ABBVIE INC.35$831
Gilead Sciences, Inc.28$420
Madrigal Pharmaceuticals14$244
Ardelyx, Inc.7$166
Ipsen Biopharmaceuticals, Inc7$145
Janssen Biotech, Inc.5$93
Takeda Pharmaceuticals U.S.A., Inc.2$64
Phathom Pharmaceuticals, Inc.3$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$40
Intercept Pharmaceuticals, Inc.1$26

Products named: LINZESS, REZDIFFRA, IBSRELA, IQIRVO, CREON, TREMFYA, VIBERZI, ENTYVIO.

Industry payments across CT — which companies pay providers there.